CEO Michael Sonnenshein said the firm’s European rollout would be done piecemeal due to various regulatory regimes and investor attitudes.

Grayscale, ETF, Europe, European UnionRead More

You might also be interested in reading Serina Therapeutics GAAP EPS of -$0.66 misses by $0.24, revenue of $0.13M.